Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Diabetol Metab Syndr. 2024 Feb 28;16(1):54. doi: 10.1186/s13098-024-01286-z.

Amélio F Godoy-Matos^{1

2}, Cynthia Melissa Valério^{1

2}, Wellington S Silva Júnior^{3

4}, João Marcello de Araujo-Neto^{1

5}, Marcello Casaccia Bertoluci^{1

6}

¹ Sociedade Brasileira de Diabetes (SBD), São Paulo, Brazil.
² Instituto Estadual de Diabetes e Endocrinologia do Rio de Janeiro (IEDE), Rio de Janeiro, RJ, Brazil.
³ Sociedade Brasileira de Diabetes (SBD), São Paulo, Brazil. [email protected].
⁴ Endocrinology Discipline, Department of Medicine I, Faculty of Medicine, Center of Biological Sciences, Universidade Federal do Maranhão (UFMA), Praca Goncalves Dias, 21, Centro, São Luís, MA, CEP 65020‑240, Brazil. [email protected].
⁵ Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.
⁶ Universidade Federal do Rio Grande Do Sul (UFRGS), Porto Alegre, RS, Brazil.

No abstract available

Publication types